Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

100 studies match

clinicaltrialsPublishedShowing 1–50 of 100 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07796373	Nemtabrutinib for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Leukemia (SLL) Refractory to Covalent Bruton Tyrosine Kinase Inhibitor or Pirtobrutinib and Previously Treated With a BCL2 Inhibitor	not yet recruiting	Phase 2	32	National Heart, Lung, and Blood Institute (NHLBI)NIH	1	Sep 30, 2026	clinicaltrials
NCT00001465	Study of the Disease Process of Lymphangioleiomyomatosis	recruiting	—	2,000	National Heart, Lung, and Blood Institute (NHLBI)NIH